3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Hu... — RxCUI 847213
RxNorm drug concept · Semantic branded drug
RxCUI 847213
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI847213
Official name3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asHumalog Mix 50/50 300 UNT per 3 ML KwikPen; HumaLOG Mix 50/50 in 3 ML Pen Injector; Humalog Mix 50/50 300 UNT per 3 ML Prefilled Pen
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)4,023 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Insulin Lispro Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Insulin lispro is a fast-acting insulin that helps your body manage blood sugar around mealtimes. It works by helping your muscles and fat cells absorb glucose from your blood, whi...
- What exactly does insulin lispro do, and why did my doctor prescribe it?
- For subcutaneous injections, you should inject insulin lispro within 15 minutes before a meal or immediately after a meal. Because it acts quickly, timing really matters — injectin...
- When exactly should I inject this insulin — before or after I eat?
🕸️ Concept Web — How 3 ML insulin lispro 50 UNT/ML / insulin lispro p... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector [Humalog Mix]
RxCUI 847213 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Insulin lispro
86009IN -
Insulin lispro protamine, human
314684IN -
Insulin lispro / insulin lispro protamine, human
816726MIN
-
Insulin lispro
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Humalog Mix
261542BN
-
Humalog Mix
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Insulin lispro / insulin lispro protamine, human Pen Injector
1653104SCDF -
Insulin lispro / insulin lispro protamine, human Injectable Product
1157460SCDG -
Insulin lispro / insulin lispro protamine, human Pen Injector [Humalog Mix]
1653106SBDF -
Humalog Mix Injectable Product
1171291SBDG -
Pen Injector
1649571DF -
Injectable Product
1151126DFG
-
Insulin lispro / insulin lispro protamine, human Pen Injector
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector
847211SCD -
Insulin lispro 50 UNT/ML
343663SCDC -
Insulin lispro protamine, human 50 UNT/ML
343262SCDC -
Insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML [Humalog Mix]
731277SBDC
-
3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector
Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
3 ML insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Pen Injector
SCD · 847211 -
Insulin lispro 50 UNT/ML
SCDC · 343663 -
Insulin lispro protamine, human 50 UNT/ML
SCDC · 343262 -
Insulin lispro / insulin lispro protamine, human Pen Injector
SCDF · 1653104 -
Insulin lispro / insulin lispro protamine, human Injectable Product
SCDG · 1157460
Brand-Name Concepts
-
Insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML [Humalog Mix]
SBDC · 731277 -
Insulin lispro / insulin lispro protamine, human Pen Injector [Humalog Mix]
SBDF · 1653106 -
Humalog Mix Injectable Product
SBDG · 1171291 -
Humalog Mix
BN · 261542
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 847213 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00002-8798-59 | 5 SYRINGE in 1 CARTON (0002-8798-59) / 3 mL in 1 SYRINGE (0... | Humalog Mix50/50 KwikPen | Eli Lilly and Company | 2008-01-16 |
Observed labelers:
Eli Lilly and Company (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$10.1510
Range $10.1510–$10.1510
· middle 50% $10.1510–$10.1510
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.